TBG Diagnostics
OverviewSuggest Edit
TBG Diagnostics is a molecular diagnostics company dedicated to the development, manufacture, and marketing of molecular diagnostics kits, instruments, and services. The company serves the clinical labs of both hospitals and independent reference labs, as well as blood centers and bone marrow registry labs.
| Type | Public | |
| Founded | 1989 | |
| Website | tbgbio.com |
Latest Updates
| Employees (est.) (Mar 2020) | 8 | |
| Share Price (Mar 2020) | $0.3 |
TBG Diagnostics Financials and Metrics
TBG Diagnostics Revenue
Market capitalization (27-Mar-2020) | 63.1m |
Closing stock price (27-Mar-2020) | 0.3 |
TBG Diagnostics's current market capitalization is $63.1 m.
TBG Diagnostics Online and Social Media Presence
TBG Diagnostics's Trends
TBG Diagnostics Frequently Asked Questions
When was TBG Diagnostics founded?
TBG Diagnostics was founded in 1989.
How many employees does TBG Diagnostics have?
TBG Diagnostics has 8 employees.
Who are TBG Diagnostics competitors?
Competitors of TBG Diagnostics include Cardiovascular Systems, ResMed Maribo and ProSomnus Sleep Technologies.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies